Which immunotherapy do you feel holds the most promise for the treatment of NSCLC?
Atezolizumab (MPDL3280A, Genentech/Roche)
MEDI4726 (MedImmune, AstraZeneca)
Nivolumab (Opdivo, Bristol-Myers Squibb)
Pembrolizumab (Keytruda, Merck)
Submit
View Results
See this poll on:
https://poll.fm/9069935/embed